Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Feb;55(4):903-908.
doi: 10.1111/ejn.15618.

Special issue editorial: Cannabinoid signalling in the brain: New vistas

Affiliations
Editorial

Special issue editorial: Cannabinoid signalling in the brain: New vistas

Arnau Busquets-Garcia et al. Eur J Neurosci. 2022 Feb.

Abstract

The endocannabinoid system is widely expressed both in the brain and in the periphery. This system regulates a plethora of physiological functions and is composed of cannabinoid receptors, their endogenous ligands, and the enzymes involved in their metabolic processes. In the last few years, the development of new imaging and molecular tools has demonstrated that these receptors are distributed in many cell types (e.g., neuronal or glial cells) and intracellular compartments (e.g., mitochondria). Interestingly, cellular or molecular effects are differentially mediated by cannabinoid receptors according to their specific localization in different cell-types or in different subcellular locations. Moreover, the endocannabinoid system is also expressed throughout the body where it can serve to modulate the connection between the brain and the periphery. Finally, better understanding of the cannabinoid receptors structure and pharmacology has led researchers to propose interesting and new allosteric modulators of synaptic communication. The latest advances and innovative research in the cannabinoid field will provide new insights and better approaches to improve its interesting potential therapeutic profile. This special issue intends to bring together a series of empirical papers, targeted reviews and opinions from leaders in the field that will highlight the new advances in cannabinoid research.

PubMed Disclaimer

References

REFERENCES

    1. Araque, A., Castillo, P. E., Manzoni, O. J., & Tonini, R. (2017). Synaptic functions of endocannabinoid signaling in health and disease. Neuropharmacology, 124, 13-24. https://doi.org/10.1016/j.neuropharm.2017.06.017
    1. Bacci, A., Huguenard, J. R., & Prince, D. A. (2004). Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature, 431, 312-316. https://doi.org/10.1038/nature02913
    1. Brunt, T. M., & Bossong, M. G. (2020). The neuropharmacology of cannabinoid receptor ligands in central signaling pathways. The European Journal of Neuroscience, 1-13. https://doi.org/10.1111/ejn.14982
    1. Busquets-Garcia, A., Bains, J., & Marsicano, G. (2018). CB1 receptor signaling in the brain: Extracting specificity from ubiquity. Neuropsychopharmacology, 43, 4-20. https://doi.org/10.1038/npp.2017.206
    1. Busquets-Garcia, A., Desprez, T., Metna-Laurent, M., Bellocchio, L., Marsicano, G., & Soria-Gomez, E. (2015). Dissecting the cannabinergic control of behavior: The where matters. BioEssays, 37, 1215-1225. https://doi.org/10.1002/bies.201500046

Publication types

MeSH terms

LinkOut - more resources